Blockbuster fellas and Gals, no middle road on this one. Many indications if the first one works, buckle up I think we finally have the real deal Holyfield
Agree, it's the single most important announcement to date for AEZS, Perifosine, AEZS-130 were not as important to their future as this indication. Hope everything goes very well for them or it could be a struggle if it fails.
One man's crushed grape is another's Cabernet Sauvignon lol, that's what makes a market, see you in Napa
AEZS can ace a phase 3 trial, let's hope whoever is making the big investment is on the right side of the outcome. Personally I've lost all confidence in this company but that's about the time they take off when the last bag holder gives up lol
for the doubters. https://finance.yahoo.com/video/coinbase-launches-licensed-bitcoin-exchange-155300189.html
Coinbase opened for business in the US on 26th, BTCS chart is vertical since the 26th, it's really going nitro when the Gemini Exchange comes online in 2015. Your in the very early stages of the Bitcoin Boom
They have an excellent patented product by all accounts (read Nation Institute of Health conclusion) except the FDA. The FDA is one of the few who doesn't think AEZS-130 isn't good enough to replace the current excellent painless test.
Is the total opposite of the other guys that's why I think Aeterna Zentaris will go elsewhere to sell their oral test. Do a search it's easy to find, read the very favorable conclusion and comments.
They walked AEZS through the whole process then decline it. FDA decisions seem biased against small biotechs, protecting the large drug companies interests. I'm sure if MRK or someone had this product the "issues" would be smoothed over.
You remember they had another approved product in this speciality that they sold off. I expect 130 to get approved for this reason, their Oncology products I'm not as confident but their Endocrinology products are awesome.
Just sayin, I added more just for this reason, I think their ship has finally come in yadayadayada
I just don't see any good arguments why it would not be approved. If 130 was going to be denied it would make sense for the FDA to let the company know by now, also phase 3 results were very promising. The price action is showing that the market is uncertain of the outcome so it's an even playing field.
Remember when Perifosine was up for approval there was a writer from Seeking Alpha who laid out all the technical reasons it would fail and he was spot on unfortunately, I don't see him saying anything negative about AEZS-130. AEZS the company is playing this one close to the vest after their last failure and I like that also. Good luck 130 I think they have a good product.
I tripled down, I now think theiy are going to get approved in Nov or sooner. I don't see any indications otherwise, no experts coming out of the woodwork bashing Mac because their smart enough to know it's getting approved and they don't want foot in mouth to damage their own reputation.
Sentiment: Strong Buy